Finally, our study points at ER homeostasis as a common pathway affected in ADTKD-REN, and possibly more generally in ADTKD, that may represent a promising therapeutic target. This evidence concerns the gene REN and autosomal dominant medullary cystic kidney disease with or without hyperuricemia.